Search results
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 10 hours agoThe institutional investor owned 30,315 shares of the biopharmaceutical company’s stock after selling 10,839 shares during the period. Weik Capital Management’s holdings in ...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com PH
Investing.com· 6 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 5 days agoThe share price’s 52-week low was $25.20, which indicates that the recent value has risen by an impressive 14.23% since then. We note from Pfizer Inc.’s ...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock.
Motley Fool via Yahoo Finance· 1 day agoAnd investing in a safe, high-yielding dividend stock can make the most of your money. That's why a ...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 4 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 1 day agoBy then, the company also projects roughly $25 billion in new revenue from business development...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 2 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 4 days agoPfizer's stock has been a disappointment in recent years as the hype from its COVID vaccine and pill...
Potential Price Increase for Pfizer Inc.
Knox Daily· 7 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the